We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What is Antithrombin?

By Lisa Cox
Updated: Mar 03, 2024

Antithrombin (AT), also known as antithrombin III (AT III), is a protein molecule and thrombin inhibitor found in blood plasma. Thrombin is one of the key parts of the body’s coagulation system, and keeping balance in this system requires that thrombin be inhibited, or inactivated. In addition to working in the coagulation system, antithrombin can act as an anti-inflammatory.

The coagulation system is a complex chain reaction designed to produce clots where and when they are needed. Clotting is the process by which blood flow to an injury, such as a cut, can be stopped so a person doesn’t bleed to death. AT works by inhibiting thrombin, Factor Xa, and Factor IXa, which are clotting enzymes. Factor Xa and Factor IXa contribute to the creation of thrombin. By working on multiple parts of the coagulation system, AT helps effectively regulate clotting.

Thrombin acts on fibrinogen to form fibrin, the essential element of a clot. Fibrin is an insoluble protein that combines with other proteins to form clots. By inhibiting thrombin, antithrombin inhibits clotting. Both of these working in concert along with other clotting factors keep the coagulation system regulated.

Antithrombin deficiency causes the coagulation system to work out of control. One AT unit is needed to inhibit one thrombin unit. If AT is taken out of this equation, the proliferation of thrombin will cause the overproduction of clots. AT only has a plasma half-life of three days, so it must be produced regularly for continued effectiveness. Just a 50 percent reduction in AT is enough to unbalance the coagulation system and cause unnecessary clotting.

Clots should be produced in response to injuries but, without AT, an imbalanced coagulation system can produce clots anywhere in the circulation system. Arteries and veins can be blocked by clots. Clots can also travel in the blood stream to critical parts of the body, such as the brain or heart, leading to stroke, heart attack, or even death. Too little clotting can be just as harmful, causing patients to bleed to death from even minor injuries.

Antithrombin deficiency can be genetic or acquired. Types of genetic antithrombin deficiencies include thrombophilia and AT III deficiency. With genetic antithrombin deficiency there can be a variety of factors that lead to abnormal clotting. The type of mutation that causes the antithrombin deficiency is important. This determines whether the effects of antithrombin deficiency become apparent in early adulthood or later in life and whether the symptoms will be mild or very serious.

Some causes of acquired antithrombin deficiency include renal failure, acute respiratory distress syndrome, pregnancy, and liver disease. Infants are susceptible to antithrombin deficiency because they naturally have less AT. This can be counteracted by alpha2-macroglobulin, a protein that is naturally found in infants and also works as a thrombin inhibitor. Bone marrow transplant patients also have a higher risk of antithrombin deficiency.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.